Author: digi

Freeze-Drying and Lyophilization Strategies for Biologics Stability

Freeze-Drying and Lyophilization Strategies for Biologics Stability Enhancing Biologics Stability Through Freeze-Drying and Lyophilization Introduction Freeze-drying, also known as lyophilization, is a widely adopted technique to stabilize protein- and peptide-based biologics by transforming them into dry, solid formulations with extended shelf life. This approach protects labile biologics from hydrolysis, aggregation, and microbial degradation during storage…

Biopharmaceutical Stability, Freeze-Drying and Lyophilization in Biologics Stability

Stability of Combination Products at Intermediate Conditions

Stability of Combination Products at Intermediate Conditions Evaluating the Stability of Combination Products at Intermediate Conditions: Challenges and Best Practices Combination products—pharmaceutical formulations that merge two or more active ingredients or integrate a drug with a device—pose unique challenges for stability testing. These challenges become especially pronounced when evaluating the product under intermediate conditions, such…

Intermediate and Long-Term Stability Testing, Stability Testing Types

Sustainable and Biodegradable Packaging in the Pharmaceutical Industry

Sustainable and Biodegradable Packaging in the Pharmaceutical Industry Innovations in Sustainable and Biodegradable Packaging for Pharmaceuticals Introduction The pharmaceutical industry faces increasing pressure to adopt environmentally responsible practices, including in its packaging systems. Traditional pharmaceutical packaging—reliant on multi-layer plastics, aluminum, and non-recyclable laminates—contributes significantly to global waste. With rising environmental awareness, stricter regulatory expectations, and…

Pharmaceutical Packaging Stability, Sustainable and Biodegradable Packaging for Pharmaceuticals

Stability Testing in Biologic Scale-Up and Manufacturing

Stability Testing in Biologic Scale-Up and Manufacturing Stability Testing Strategies During Biologic Scale-Up and Commercial Manufacturing Transitioning from clinical-scale production to commercial manufacturing is a critical milestone in the lifecycle of biologic drugs. As processes are scaled up, it’s essential to ensure that product stability remains consistent and well-documented. Variability in equipment, raw materials, and…

Stability Testing for Biopharmaceuticals, Stability Testing Types

Freeze-Thaw Cycle Optimization for Reduced Study Time

Freeze-Thaw Cycle Optimization for Reduced Study Time Freeze-Thaw Cycle Optimization for Reduced Study Time in Pharmaceutical Stability Studies Freeze-thaw stability studies are a critical component of pharmaceutical development, especially for cold chain products like biologics, vaccines, and emulsions. Traditionally, these studies involve multiple freeze-thaw cycles spanning weeks, which can delay development timelines. However, with a…

Freeze-Thaw and Thermal Cycling Studies, Stability Testing Types

SOP for Conducting Stability Studies for Modified Release Products per FDA and ICH Guidelines

SOP for Conducting Stability Studies for Modified Release Products per FDA and ICH Guidelines Guidelines for Stability Testing of Modified Release Products 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide a procedure for conducting stability studies of modified release drug products in accordance with US FDA and ICH guidelines. This…

Stability Studies SOP

Sustainable Packaging for Drug Stability in Pharmaceuticals

Sustainable Packaging for Drug Stability in Pharmaceuticals Sustainable Packaging for Drug Stability: Bridging Environmental Goals and Product Integrity Introduction Pharmaceutical companies are increasingly being challenged to reduce their environmental footprint without compromising product quality or regulatory compliance. Packaging, a major contributor to the industry’s carbon emissions and waste, has become a central focus in these…

Packaging and Containers, Sustainable Packaging for Drug Stability

Risk-Based Selection of Testing Intervals in Long-Term Stability Studies

Risk-Based Selection of Testing Intervals in Long-Term Stability Studies Implementing Risk-Based Selection of Testing Intervals in Long-Term Stability Studies Long-term pharmaceutical stability studies traditionally follow fixed schedules, testing batches at predetermined intervals like 0, 3, 6, 9, 12, 18, 24, and 36 months. However, a more strategic approach—grounded in product knowledge and degradation risk—can help…

Intermediate and Long-Term Stability Testing, Stability Testing Types

Good Manufacturing Practices (GMP) for Stability Studies in Pharmaceuticals

Good Manufacturing Practices (GMP) for Stability Studies, Pharmaceutical Quality and Practices

Include In-Use Stability Studies for Reconstituted and Multidose Formulations

Understanding the Tip: Why in-use studies are essential: In-use stability studies evaluate how a pharmaceutical product performs after it has been opened, reconstituted, or prepared for administration. This simulates real-world usage conditions—where contamination, moisture, or temperature shifts may alter the product’s stability. Such studies are critical for multidose containers, injectables that require dilution, or powders…

Stability Study Tips